RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,642,573 entitled “Methods of Treating Hepatic Encephalopathy.” This patent is eligible for Orange Book listing for the Company’s hepatic encephalopathy indication and provides protection until October 2029.
Help employers find you! Check out all the jobs and post your resume.
